16 related articles for article (PubMed ID: 3783580)
1. Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)ones.
Pinna GA; Curzu MM; Barlocco D; Cignarella G; Cavalletti E; Germini M; Berger K
Farmaco Sci; 1988 Jun; 43(6):539-49. PubMed ID: 3208896
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of substituted benzo[h]cinnolinones and 3H-benzo[6,7]cyclohepta[1,2-c]pyridazinones: higher homologues of the antihypertensive and antithrombotic 5H-indeno[1,2-c]pyridazinones.
Cignarella G; Barlocco D; Pinna GA; Loriga M; Curzu MM; Tofanetti O; Germini M; Cazzulani P; Cavalletti E
J Med Chem; 1989 Oct; 32(10):2277-82. PubMed ID: 2795599
[TBL] [Abstract][Full Text] [Related]
3. New congeners of antihypertensive and antithrombotic 7-amino or 7-acetyl-aminosubstituted-4,4a-dihydro-5H-indeno (1,2-c)pyridazin-3-ones.
Cignarella G; Barlocco D; Landriani L; Folloni M; Pinna GA; Sala F; Germini M
Farmaco Sci; 1988 Feb; 43(2):169-79. PubMed ID: 3391263
[TBL] [Abstract][Full Text] [Related]
4. [Unexpected anti-inflammatory activity of rigid structure derivatives of 6-arylpyridazinone antihypertensives. I. Synthesis and activity of 4,4a-dihydro-5H-indeno[1,2c]pyridazin-3-ones].
Cignarella G; Grella G; Loriga M; Curzu MM; Schiatti G
Farmaco Sci; 1978 Nov; 33(11):866-74. PubMed ID: 744241
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 4,4a,5,6-tetrahydro-7,8-disubstituted-benzo[h]cinnolin-3(2H)-ones.
Pinna GA; Loriga M; Curzu MM; D'Amico M
Farmaco; 1997 Jan; 52(1):25-8. PubMed ID: 9181677
[TBL] [Abstract][Full Text] [Related]
6. Conformationally restricted congeners of hypotensive and platelet aggregation inhibitors: 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones derived from 5H-indeno[1,2-c]pyridazine.
Cignarella G; Barlocco D; Pinna GA; Loriga M; Tofanetti O; Germini M; Sala F
J Med Chem; 1986 Nov; 29(11):2191-4. PubMed ID: 3783580
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory activity of pyridazinones: A review.
Hassan MSA; Ahmed EM; El-Malah AA; Kassab AE
Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200067. PubMed ID: 35532263
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
